Intracellular Accumulations

Slide 1 · Intracellular Accumulations

Mechanisms · Lipid storage · Protein inclusions · Glycogen

Cell injury, cell death, and adaptations

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Classify the four major mechanisms of abnormal intracellular accumulation.

Interpret the morphologic patterns of lipid, protein, and glycogen accumulation.

Relate selected histologic inclusions to metabolic, secretory, and degradative defects.

Distinguish potentially reversible storage from progressive storage-associated injury.

Slide 3 · Accumulation is a manifestation of metabolic derangement

Cells may accumulate substances that are normal or abnormal, endogenous or exogenous.

Storage may be incidental and harmless, or contribute to cellular dysfunction and injury.

The accumulated material may originate within the affected cell or elsewhere.

Accumulation is a morphologic pattern, not by itself a diagnosis.

Slide 4 · Cellular localization helps explain the mechanism

Cytoplasmic deposits can reflect disordered metabolism or excess protein synthesis.

Organelles—especially lysosomes—may retain incompletely degraded substrate.

The source also recognizes nuclear accumulation in some settings.

Schematic — not histology

Illustrative lysosomal compartment

Slide 5 · Origin: Material synthesized in the cell or acquired

Origin

Route to accumulation

Example

Endogenous / synthesized

Formation exceeds processing or secretion

Triglycerides in hepatocytes

Endogenous / undegraded

Defective disposal of a metabolite

Lysosomal storage disorders

Exogenous / taken up

Phagocytosed material cannot be removed

Carbon or silica particles

Slide 6 · Four principal pathways to intracellular accumulation

1 Normal substrate

Inadequate metabolic processing, removal, or transport

2 Endogenous abnormal protein

Defective folding, intracellular transport, or secretion

3 Lysosomal degradation

Inherited enzyme deficiency prevents breakdown

4 Exogenous material

Indigestible particles remain in the receiving cell

Slide 7 · The intracellular balance is a flux problem

Substrate enters or forms

Cell processes / transports it

Material exits or degrades

Accumulation occurs when input and formation exceed effective processing or clearance.

A visible deposit can therefore indicate a biochemical bottleneck rather than increased synthesis alone.

Slide 8 · Mechanism 1: Inadequate removal of a normal substrate

Normal cellular substance

Defective processing / transport

Intracellular retention

The substance itself need not be abnormal.

Hepatic triglyceride accumulation illustrates disturbed handling of a physiological lipid.

Slide 9 · Mechanism 2: Folding or secretion is defective

Abnormal or misfolded protein

Impaired ER processing

Retained protein aggregates

Mutant α1-antitrypsin is a representative example.

Local retention and deficient secretion can produce different organ consequences.

Slide 10 · Mechanism 3: Lysosomal breakdown fails

Macromolecular substrate

Absent / ineffective enzyme

Lysosomal storage

Inherited deficits in degradative enzymes impair the conversion of complex substrates into products.

Continued substrate delivery may make the deposits progressive.

Slide 11 · Mechanism 4: Indigestible exogenous material persists

Exposure and particle uptake

No effective degradation / export

Particle retention

Carbon and silica are examples of inhaled material retained after cellular uptake.

Accumulation can persist because the receiving cell lacks a relevant removal pathway.

Slide 12 · Match accumulation mechanisms with examples

Dominant failure

Illustrative condition

Underlying logic

Normal-substrate processing

Steatosis

Triglyceride handling is inadequate

Folding / trafficking

α1-antitrypsin-related inclusions

Protein remains in the endoplasmic reticulum

Enzyme-mediated degradation

Lysosomal storage disease

Substrate cannot be degraded

Disposal of exogenous material

Carbon or silica storage

Material cannot be metabolized or exported

Slide 13 · Reversibility depends on the source of overload

Setting

Expected course

Reason

Overload can be stopped

Potentially reversible

Intracellular burden can be processed or cleared

Persistent inability to degrade substrate

Often progressive

Substrate continues to accumulate

Advanced tissue injury

May be irreversible

Loss of viable cells or tissue architecture

Slide 14 · Storage becomes harmful through cellular dysfunction

Persistent intracellular burden

Compartmental or proteostatic stress

Cell dysfunction / death

The source explicitly distinguishes innocuous accumulation from injury-producing accumulation.

Severity depends on substance, cellular context, duration, and ability to restore homeostasis.

Slide 15 · The accumulated molecule determines the morphologic pattern

Stored material

Representative finding

Common compartment

Triglyceride

Clear cytoplasmic vacuoles

Parenchymal cell cytoplasm

Protein

Pink eosinophilic droplets or inclusions

Cytoplasm / ER

Glycogen

Pale or clear cytoplasmic spaces

Cytoplasm

Complex undegraded substrates

Lysosomal enlargement / inclusion

Lysosomes

Slide 16 · Different lipid classes can accumulate

Triglycerides, cholesterol and cholesterol esters, and phospholipids can accumulate in cells.

Phospholipids are constituents of myelin figures associated with necrotic cells.

Complex lipid–carbohydrate substrates can accumulate in lysosomal storage disorders.

This lecture emphasizes triglyceride steatosis; Cholesterol accumulation is treated separately.

Slide 17 · Steatosis is abnormal triglyceride storage

Steatosis, or fatty change, refers to excess triglycerides within parenchymal cells.

The liver is the principal organ affected because of its central role in lipid metabolism.

An intracellular fat vacuole is the morphologic expression of this accumulation.

Schematic — not histology

Large triglyceride droplet with nuclear displacement

Slide 18 · Fatty change also occurs outside the liver

Organ

Potential cellular site

Interpretive point

Liver

Hepatocytes

Most common and conspicuous site

Heart

Myocardial cells

Fatty change may accompany injury

Skeletal muscle

Myocytes

Parenchymal lipid storage

Kidney

Renal tubular cells

Lipid can accumulate in tubular epithelium

Slide 19 · Why the liver is particularly susceptible

Lipid processing is central

Triglyceride handling is disturbed

Hepatocyte stores lipid

Normal hepatic lipid metabolism makes the hepatocyte vulnerable to an imbalance of storage and removal.

The morphologic lesion is storage; The cause must be established from clinical context.

Slide 20 · The causes of steatosis are diverse

Category

Source-described examples

Interpretive point

Metabolic

Diabetes mellitus; obesity

Requires systemic metabolic context

Toxic

Excessive alcohol; other toxins

Exposure history is important

Nutritional

Protein malnutrition

Disordered nutrient handling may contribute

Hypoxic

Anoxia

Reduced oxygen availability accompanies injury

Slide 21 · Diabetes and obesity are frequent clinical associations

The source identifies diabetes and obesity among the causes of hepatic fatty change.

Insulin resistance and broader metabolic abnormalities commonly coexist with steatotic liver disease.

Steatosis should not be assigned a single etiology on morphology alone.

Slide 22 · Alcohol exposure can produce early hepatic steatosis

Alcohol exposure

Hepatocellular lipid droplets

Predominant macrovesicular fat

In the liver chapter, steatosis is described as an early effect of alcohol exposure.

With ongoing injury, inflammation and fibrosis may develop; Fat alone does not establish steatohepatitis.

Slide 23 · The textbook uses evolving fatty-liver nomenclature

Location in textbook

Terminology used

Teaching interpretation

Chapter 2 overview

Nonalcoholic fatty liver disease

Older umbrella terminology retained in this passage

Chapter 18 liver discussion

Metabolic dysfunction–associated steatotic liver disease (MASLD)

Updated metabolic-dysfunction framing

Slide 24 · Fat vacuoles appear optically clear in routine sections

Triglyceride droplets form rounded clear cytoplasmic spaces after routine processing.

The vacuoles vary in size and distribution.

Interpret the pattern in the context of the affected organ.

Schematic of cellular appearances — not a specimen

Slide 25 · A large fat droplet displaces the hepatocyte nucleus

A dominant droplet expands within the cytoplasm.

The nucleus is compressed toward the cellular periphery.

The remaining cytoplasm forms a narrow surrounding rim.

Schematic — not histology

Schematic of a fat-loaded hepatocyte

Slide 26 · Small lipid droplets may coalesce into large droplets

Small cytoplasmic droplets

Droplet coalescence

Large vacuole + displaced nucleus

The liver chapter describes progression from small droplets to larger vacuoles in alcohol-associated steatosis.

The diagram represents a conceptual morphologic sequence, not a measured temporal rate.

Slide 27 · Macrovesicular and microvesicular patterns differ

Pattern

Morphologic principle

Textbook context

Macrovesicular

Large droplets may push nuclei aside

Predominant in alcohol-associated steatosis

Microvesicular

Numerous fine lipid droplets in a cell

Recognized form of fatty change

Mixed

Droplets of different sizes coexist

Described in some settings

Slide 28 · Gross fatty liver can be enlarged and yellow

In chronic alcohol-associated injury, the fatty liver may be enlarged, soft, yellow, and greasy.

Gross color and texture reflect tissue lipid deposition, but are not etiologic proof.

Microscopy and clinical history distinguish steatosis from accompanying injury.

Slide 29 · Simple steatosis may regress when injury stops

Remove continuing insult

Lipid burden decreases

Cellular architecture may normalize

The source notes that uncomplicated fatty change is often reversible after the cause is removed.

Established fibrotic remodeling is a different process and is less completely reversible.

Slide 30 · Steatosis is not synonymous with steatohepatitis

Simple steatosis

Steatohepatitis

Intracellular triglyceride accumulation

Steatosis with hepatocyte injury and inflammatory change

Fat droplets may be prominent

Ballooning, cell injury, and potentially fibrosis

Potentially reversible storage

Risk of progressive fibrotic disease

Slide 31 · Clinical expression of steatosis varies

Hepatomegaly may result from extensive lipid accumulation.

The source notes that substantial hepatic dysfunction is unusual in uncomplicated alcohol-associated steatosis.

Clinical and laboratory abnormalities require assessment for concurrent inflammation, fibrosis, or other disease.

Slide 32 · Application 1: Identify hepatic fatty change

A patient with obesity has hepatomegaly. A tissue section contains hepatocytes with rounded clear cytoplasmic vacuoles; Many nuclei lie at the cell margin.

Which stored material best explains this pattern?

Triglyceride

Retained immunoglobulin

Glycogen alone

Slide 33 · Application 1: The pattern is steatosis

Clear cytoplasmic droplets

Peripheral nuclear displacement

Triglyceride accumulation

The lesion is called fatty change or steatosis.

The morphologic diagnosis does not determine whether alcohol, metabolic dysfunction, or another cause is responsible.

Slide 34 · Intracellular protein deposits have varied morphologies

Light microscopy may show rounded eosinophilic droplets, vacuoles, or aggregates.

At ultrastructural level, retained material may be amorphous, fibrillar, or crystalline.

Protein accumulations arise from several different mechanisms.

Schematic — not histology

Conceptual protein inclusions

Slide 35 · Not all deposited protein is intracellular

Intracellular accumulation

Extracellular deposition

Protein droplets or inclusions inside a cell

Protein deposited in interstitial/extracellular spaces

Examples: reabsorption droplets, Russell bodies

Certain amyloid deposits are primarily extracellular

Can reflect uptake, synthesis, or retention

Requires distinct molecular and tissue interpretation

Slide 36 · Protein uptake is normal in renal proximal tubules

Small filtered protein load

Proximal tubular pinocytosis

Intracellular processing

Normally, small amounts of protein filtered at the glomerulus are reabsorbed by proximal tubules.

Increased filtered protein can exceed the ordinary processing capacity.

Slide 37 · Proteinuria produces proximal tubular reabsorption droplets

High glomerular protein leak

Enhanced tubular reabsorption

Eosinophilic cytoplasmic droplets

Abundant reabsorbed protein collects in vesicular structures within tubular epithelial cells.

The source describes these deposits as pink hyaline droplets in routine sections.

Slide 38 · Protein reabsorption droplets can disappear

Proteinuria decreases

Protein load declines

Droplets are metabolized

The source explicitly identifies this uptake-related accumulation as reversible.

The example illustrates accumulation from excess supply rather than a primary mutant protein.

Slide 39 · Russell bodies result from excess immunoglobulin synthesis

Active immunoglobulin synthesis

ER distension with retained protein

Eosinophilic Russell bodies

Certain plasma cells produce more secretory protein than can be processed immediately.

Their distended endoplasmic reticulum forms large homogeneous inclusions.

Slide 40 · Renal droplets and Russell bodies have different origins

Feature

Proximal tubule droplet

Russell body

Origin

Filtered protein taken up from lumen

Immunoglobulin synthesized by plasma cell

Primary mechanism

Excess reabsorption burden

Increased secretory protein production

Characteristic site

Renal tubular epithelium

Plasma cell cytoplasm / ER

Interpretive context

Proteinuric renal disease

Antibody-producing plasma cells

Slide 41 · Mutant α1-antitrypsin is retained in hepatocytes

Protein-folding mutation

Slow folding + aggregation

Retention in hepatocyte ER

Partially folded protein intermediates aggregate instead of being efficiently secreted.

The source identifies α1-antitrypsin deficiency as a model of defective intracellular processing.

Slide 42 · α1-antitrypsin deficiency links liver and lung injury

Hepatocyte

Pulmonary tissue

Misfolded protein remains in ER

Less circulating antiprotease reaches tissue

Cellular protein retention and stress

Insufficient protection against proteolytic injury

Local aggregate-associated damage

Emphysema can develop

Slide 43 · Misfolded proteins trigger ER stress responses

Unfolded protein load

Unfolded protein response

Adaptation or apoptosis

The source associates accumulated misfolded proteins with ER stress.

If proteostasis cannot be restored, the cellular response may culminate in apoptotic death.

Slide 44 · Protein retention can produce two forms of pathology

Gain-of-toxic-burden effect

Loss-of-function effect

Protein accumulates in producing cell

Functional protein is absent from its destination

ER stress / proteostasis disturbance

Reduced activity in dependent tissue

Example: hepatocyte α1-antitrypsin retention

Example: pulmonary antiprotease deficiency

Slide 45 · Cytoskeletal accumulations involve structural proteins

Intermediate filaments form an intracellular scaffold that supports cellular organization and mechanical stability.

Keratin filaments characterize epithelial cells; Neurofilaments characterize neurons.

Abnormally concentrated filaments can become visible as pathologic inclusions.

Slide 46 · Alcoholic hyaline is a keratin-rich hepatocyte inclusion

The source describes alcoholic hyaline in liver cells as an eosinophilic cytoplasmic inclusion.

It consists predominantly of keratin intermediate-filament proteins.

The liver chapter calls this inclusion Mallory hyaline in the setting of hepatocyte injury.

Schematic — not histology

Conceptual protein inclusion

Slide 47 · Neurofibrillary tangles are protein aggregates

The source cites neurofibrillary tangles in Alzheimer disease as an example of protein accumulation.

They contain neurofilaments and other proteins.

An intracellular inclusion is therefore not limited to a metabolic liver or renal disorder.

Slide 48 · Abnormal protein aggregation is a broad disease mechanism

Property

Pathologic implication

Misfolded or abnormal protein

May aggregate or deposit

Location varies

Intracellular, extracellular, or both

Biological effect varies

Direct or indirect impairment of cellular function

Example disease class

Proteinopathies / protein-aggregation diseases

Slide 49 · Biomolecular condensates: An evolving interpretation

The source notes that some inclusion bodies may behave as concentrated, dynamic protein assemblies.

Liquid–liquid phase separation may contribute to the formation of these assemblies.

Whether these inclusions drive disease progression, protect cells, or do both remains under investigation.

Emerging mechanistic interpretation — avoid treating all inclusions as proven causal condensates.

Slide 50 · “Hyaline” is a histologic description, not a substance

Hyaline describes a homogeneous, glassy, eosinophilic appearance on routine H&E sections.

The term encompasses different biochemical compositions and pathogenic settings.

Hyaline change is not inherently specific for cell injury or a single form of accumulation.

Slide 51 · Intracellular and extracellular hyaline are distinct

Intracellular hyaline

Extracellular hyaline

Protein reabsorption droplets

Hyalinized collagen in old scars

Russell bodies

Hyaline material in thickened arteriolar walls

Alcoholic / Mallory hyaline

Plasma proteins and basement membrane material may contribute

Slide 52 · Do not diagnose a molecular substrate from pink color alone

Homogeneous eosinophilia

Identify compartment and cell

Use context and targeted studies

A pink glassy appearance does not establish the specific stored protein.

Location, clinical setting, and additional examination are needed to characterize the lesion.

Slide 53 · Glycogen is a normal intracellular glucose reserve

Healthy cells store glycogen in the cytoplasm as an accessible glucose reserve.

Excess glycogen accumulation occurs with abnormal glucose or glycogen metabolism.

Both acquired metabolic disorders and inherited glycogenoses may produce deposits.

Slide 54 · Glycogen accumulation may resemble clear vacuolation

With aqueous tissue processing, glycogen can dissolve and leave optically clear cytoplasmic areas.

The resulting pale or vacuolated appearance is not specific for glycogen.

Chemical staining is required to support substrate identification.

Schematic of cellular appearances — not a specimen

Slide 55 · Fixation affects glycogen preservation

Aqueous fixatives

Absolute alcohol

Glycogen may be dissolved or lost

Better preservation of glycogen in tissues

H&E appearance can be clear / vacuolated

Stored polysaccharide more readily retained

Vacuolation remains nonspecific

Substrate still needs appropriate stain confirmation

Slide 56 · PAS and Best carmine can detect glycogen

Periodic acid–Schiff (PAS) staining may impart rose-to-violet color to glycogen.

Best carmine is another stain used to demonstrate glycogen.

PAS also stains other carbohydrate-containing compounds, so initial positivity is not proof of glycogen.

Slide 57 · Diastase digestion confirms glycogen staining

PAS-positive tissue

Diastase on matched section

Loss of glycogen signal

Diastase hydrolyzes glycogen; Disappearance of PAS staining supports a glycogen substrate.

Persistently PAS-positive material after diastase treatment can reflect other carbohydrates or glycoproteins.

Slide 58 · Diabetes can cause glycogen accumulation in several cells

Anatomical site

Source-described location

Kidney

Renal tubular epithelial cells

Liver

Hepatocytes

Pancreas

Islet β cells

Heart

Cardiac myocytes

Slide 59 · Glycogenoses reflect inherited metabolic enzyme defects

Inherited enzyme abnormality

Abnormal glycogen synthesis or breakdown

Cellular glycogen overload

Glycogen storage diseases can cause massive accumulation in selected cells.

Severe inherited storage can lead to cellular dysfunction and cell death.

Slide 60 · Acquired and inherited glycogen deposition differ

Metabolic context

Inherited storage context

Diabetes mellitus

Glycogen storage diseases (glycogenoses)

Altered glucose metabolism

Inherited defect of glycogen metabolic enzymes

Specific organs show deposits

Selected tissues may accumulate massive glycogen

Clinical disease context is essential

Potential progressive cell injury

Slide 61 · Clear cytoplasm: Triglyceride or glycogen?

Feature

Triglyceride accumulation

Glycogen accumulation

Routine histology

Clear lipid vacuoles; large droplets can displace nucleus

Pale or vacuolated cytoplasm after glycogen loss

Useful conceptual clue

Large droplet with peripheral nucleus

PAS-positive, diastase-sensitive material

Primary lesion

Steatosis

Glycogen deposition

Interpretation

Requires etiologic context

Requires substrate confirmation

Slide 62 · Protein, fat, and glycogen each require a different test

Suspected material

Typical morphology

Interpretive strategy

Triglyceride

Clear cytoplasmic droplets

Cell pattern and metabolic/toxic context

Protein

Eosinophilic droplets / aggregates

Cell identity; location; secretory / uptake context

Glycogen

Pale or clear cytoplasm

PAS with diastase comparison

Undegraded substrate

Lysosomal burden

Inherited enzyme and substrate context

Slide 63 · Application 2: Renal protein droplets

A patient with marked urinary protein loss has proximal renal tubular cells packed with rounded eosinophilic droplets. Proteinuria subsequently diminishes.

Which mechanism best explains the inclusions?

Enhanced uptake of filtered protein

Mutant α1-antitrypsin retention

Abnormal triglyceride clearance

Slide 64 · Application 2: Increased reabsorption is the mechanism

Glomerular protein leakage

Excess proximal tubular uptake

Reabsorption droplets

The accumulation is related to protein handling rather than abnormal protein synthesis.

Droplets can be metabolized after the filtered protein burden decreases.

Slide 65 · Application 3: Inclusion with deficient secreted protein

A hepatocyte contains retained misfolded secretory protein. The same disorder causes inadequate circulating antiprotease activity and pulmonary emphysema.

Which accumulation mechanism is illustrated?

Defective folding, transport, or secretion

Excess filtered protein uptake

Diastase-sensitive glycogen deposition

Slide 66 · Application 3: Intracellular retention plus functional deficit

Abnormal α1-antitrypsin folding

Hepatic ER retention

Low circulating antiprotease

Local retention creates protein burden in hepatocytes.

Deficient circulating protein has consequences in the lung.

Slide 67 · Application 4: PAS-positive hepatic storage

Hepatocytes are pale and show cytoplasmic PAS positivity. The material disappears on staining after diastase digestion.

What accumulated material is supported by this result?

Glycogen

Triglyceride

Keratin intermediate filaments

Slide 68 · Application 4: Diastase-sensitive PAS identifies glycogen

PAS highlights carbohydrate

Diastase hydrolyzes glycogen

Loss of stain confirms substrate

Positive PAS staining alone would not establish glycogen.

Interpret subsequent diagnosis in the setting of diabetes, an inherited glycogenosis, or other relevant metabolic context.

Slide 69 · Synthesis: Substance, mechanism, and clinical context

Pattern

Representative mechanism

Illustrative lesion

Lipid storage

Inadequate normal-substrate handling

Steatotic hepatocyte

Protein droplet

Excess uptake / synthesis

Tubular droplets or Russell bodies

Abnormal protein inclusion

Failed folding and secretion

Retained α1-antitrypsin

Glycogen storage

Glucose/glycogen metabolic disturbance

PAS-positive, diastase-sensitive deposits

Slide 70 · References and visual evidence

Core textbook

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. 2026. Chapter 2: Cell Injury, Cell Death, and Adaptations.

Supporting intratextbook context: Chapter 18, Liver and Gallbladder, steatosis and alcohol-associated liver disease.

Source illustration limitation

The supplied textbook was available as extracted Markdown, without original diagnostic plates. All drawings in this deck are original editable schematics; none is presented as an authentic micrograph.